RANI Rani Therapeutics
- 6.670
- -0.010-0.15%
Rani Therapeutics News
Rani Therapeutics | ARS: Annual Report to Security Holders
Rani Therapeutics | DEFA14A: Others
Rani Therapeutics | DEF 14A: Definitive information statements
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer McKinley Kate
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hashim Mir
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Groen Eric
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Imran Talat
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sanford Svai S
Rani Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Rani Therapeutics | 10-K: Annual report
Rani Therapeutics | 8-K: Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update
Rani Therapeutics | 8-K: Current report
Rani Therapeutics | 8-K: Current report
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Sanford Svai S
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hashim Mir
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ausiello Dennis A
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Imran Talat
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BUTEL JEAN LUC
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-General Counsel Groen Eric
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nanavaty Maulik
Analysis
Price Target
No Data
